Development
The Clorox Company
CLX
$122.17
$0.590.49%
NYSE
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 43.58% | -31.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.58% | -31.35% | |||
| Cost of Revenue | 33.33% | -27.26% | |||
| Gross Profit | 59.48% | -36.86% | |||
| SG&A Expenses | 17.78% | -20.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -142.86% | -72.00% | |||
| Total Operating Expenses | 26.75% | -25.71% | |||
| Operating Income | 341.89% | -70.75% | |||
| Income Before Tax | 368.97% | -87.76% | |||
| Income Tax Expenses | 900.00% | -92.86% | |||
| Earnings from Continuing Operations | 284.00% | -86.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 40.00% | |||
| Net Income | 322.73% | -87.50% | |||
| EBIT | 341.89% | -70.75% | |||
| EBITDA | 184.44% | -55.74% | |||
| EPS Basic | 321.92% | -87.51% | |||
| Normalized Basic EPS | 499.01% | -79.16% | |||
| EPS Diluted | 340.53% | -87.97% | |||
| Normalized Diluted EPS | 500.08% | -79.13% | |||
| Average Basic Shares Outstanding | 0.16% | 0.12% | |||
| Average Diluted Shares Outstanding | -0.02% | 0.01% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.76% | 7.16% | |||